Do we Still Need Human Embryonic Stem Cells for Stem Cell-Based Therapies? Epistemic and Ethical Aspects.
(2011) In Stem Cell Reviews and Reports 7. p.761-774- Abstract
- While scientific community disagrees about similarities and differences between human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) cells, some politicians embrace translational hiPS cell research as a replacement for translational hES cell research. We examine the ethical relevance of the main differences between hES and hiPS cell-based therapies and discuss whether, given the current state of knowledge, certain differences are essential. We discuss whether well-founded preferences can be made in hypothetical scenarios with varying levels of patient safety, treatment efficacy, treatment accessibility and ethical controversy.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1937548
- author
- Hug, Kristina LU and Hermerén, Göran LU
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Stem Cell Reviews and Reports
- volume
- 7
- pages
- 761 - 774
- publisher
- Springer
- external identifiers
-
- wos:000297597800001
- pmid:21461713
- scopus:82355161200
- ISSN
- 2629-3269
- DOI
- 10.1007/s12015-011-9257-3
- language
- English
- LU publication?
- yes
- id
- 5cfb74d5-f852-42b8-9028-d27e39b53c81 (old id 1937548)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/21461713?dopt=Abstract
- date added to LUP
- 2016-04-04 08:41:11
- date last changed
- 2022-12-22 08:44:53
@article{5cfb74d5-f852-42b8-9028-d27e39b53c81, abstract = {{While scientific community disagrees about similarities and differences between human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) cells, some politicians embrace translational hiPS cell research as a replacement for translational hES cell research. We examine the ethical relevance of the main differences between hES and hiPS cell-based therapies and discuss whether, given the current state of knowledge, certain differences are essential. We discuss whether well-founded preferences can be made in hypothetical scenarios with varying levels of patient safety, treatment efficacy, treatment accessibility and ethical controversy.}}, author = {{Hug, Kristina and Hermerén, Göran}}, issn = {{2629-3269}}, language = {{eng}}, pages = {{761--774}}, publisher = {{Springer}}, series = {{Stem Cell Reviews and Reports}}, title = {{Do we Still Need Human Embryonic Stem Cells for Stem Cell-Based Therapies? Epistemic and Ethical Aspects.}}, url = {{http://dx.doi.org/10.1007/s12015-011-9257-3}}, doi = {{10.1007/s12015-011-9257-3}}, volume = {{7}}, year = {{2011}}, }